BioSpace News Archive

Agiliti, Inc., a leading, nationwide provider of medical equipment management and service solutions, is partnering with U.S. hospitals and federal and state agencies on the front lines of the COVID-19 pandemic to deliver critical services where they’re needed..

Radiation Shield Technologies announced its introduction of Demron C reusable, full-body, anti-viral personal-protective equipment for healthcare workers, first responders, and other high-risk individuals at the frontlines of the Covid-19 pandemic.

Medical Devices & Diagnostics (MD&D) companies know they are being impacted by the current pandemic and are seeking independent research to quantify how much their markets will decline or increase, how long the recovery will take, and what factors will determine that recovery.

A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective COVID-19 treatment for very ill patients who also have multiple myeloma and other blood cancers

The Montreal Heart Institute Foundation is proud to announce that philanthropist Sophie Desmarais will be supporting the Montreal Heart Institute’s research projects thanks to a $1 million donation that will be used by the Research Centre for their ColCorona study.

VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced the completion of its previously announced registered direct offering of 7,218,750 shares of the Company’s common stock at a purchase price of $1.60 per share for gross proceeds of $11.55 million

Kala Pharmaceuticals, Inc. announced that the underwriters of its previously announced underwritten public offering of common stock, which closed on March 13, 2020, have exercised a portion of their option to purchase additional shares of common stock at the public offering price, less underwriting discounts and commissions.

Curis, Inc. announced that on April 1, 2020, the independent Compensation Committee of the Board of Directors of Curis approved the grant of inducement stock options to purchase a total of 110,000 shares of Curis common stock to three new employees, with a grant date of April 1, 2020.

Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring system for people with diabetes, announced that it had made equity grants to new employees under its 2019 Inducement Plan in accordance with NYSE American Company Guide Section 711.

Flexion Therapeutics, Inc. announced equity inducement grants to seven new employees consisting of 9,265 restricted stock units.